Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-09-09

Clinical Trial Update: Photobiomodulation on Neuropathic Pain and Sensation Post-mastectomy [NA]

View source ↗

Summary

A Tufts University clinical trial evaluating photobiomodulation for neuropathic pain and sensation changes after mastectomy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Tufts University | Conditions: Neuropathic Pain, Sensation Disorders | NA | Status: WITHDRAWN